Osteomalacia

Osteomalacia is a systemic metabolic bone disease characterized by defective mineralization of newly formed osteoid in mature bone.[1][2] The condition results from chronic depletion of calcium, phosphate, or both, most commonly due to severe vitamin D deficiency, though heritable disorders of phosphate metabolism, renal tubular dysfunction, and tumor-induced mechanisms are also recognized etiologies.[3][4] In the jaws, osteomalacia produces generalized osteopenia with thinning and porosity of cortical and trabecular bone; the pathognomonic radiographic hallmark is the Looser zone (pseudofracture), a lucent line perpendicular to the cortical surface.[1][5] Management is directed at the underlying metabolic cause, primarily through vitamin D and mineral supplementation, with surgical intervention reserved for causative tumors or severe skeletal deformity.[3][6]

The term "osteomalacia" (from Greek: osteon, bone; malakia, softness) refers specifically to defective mineralization of preformed osteoid in skeletally mature bone.[2][7] In children with open growth plates, the same mineralization defect at the epiphyseal cartilage is termed "rickets," and the two conditions coexist during skeletal growth.[4][6] The designation "oncogenic osteomalacia" or "tumor-induced osteomalacia" (TIO) applies when a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23 (FGF23) is the cause. "Renal osteodystrophy" encompasses the spectrum of skeletal findings in chronic kidney disease, of which osteomalacia is one component.[8][9][10] The term should not be confused with osteoporosis, which involves loss of bone mass with preserved mineralization, or with hypophosphatasia, a genetic disorder of alkaline phosphatase deficiency that produces a distinct mineralization defect.[1][4]

Osteomalacia affects both sexes and all age groups, though clinical presentation varies by etiology:

• Nutritional osteomalacia is the most common form worldwide, driven by vitamin D and/or calcium deficiency. It predominates in high-latitude regions among individuals with dark skin, limited sun exposure, and dietary insufficiency, and is increasingly recognized in tropical countries due to sun-avoidance behavior. Postmenopausal women and the elderly are disproportionately affected.[6][7]
• Heritable forms — X-linked hypophosphatemia (XLH) is the most common genetic cause, presenting in childhood with skeletal and dental manifestations that persist into adulthood. Rarer genetic causes include vitamin D–dependent rickets types I and II, hereditary hypophosphatemic rickets with hypercalciuria, and hypophosphatasia.[4][11][12][13]
• Tumor-induced osteomalacia is ultrarare, with phosphaturic mesenchymal tumors occurring at any anatomic site including the craniofacial skeleton.[8][14]

Jaw involvement mirrors the systemic skeletal disease and is not site-specific within the maxilla or mandible, though the mandible — particularly the inferior cortex — is the most readily assessed region on dental radiographs.[5][15]

Symptoms and Presentation

Osteomalacia in adults presents insidiously with nonspecific complaints including diffuse bone pain, muscle weakness, fatigue, and difficulty walking.[2][7] Jaw-specific symptoms are uncommon but may include poorly localized facial or jaw pain and tenderness on palpation of the alveolar ridges.

Dental Manifestations

• Enamel hypoplasia of primary and permanent teeth occurs when vitamin D deficiency is present during odontogenesis, resulting in irreversible structural defects and increased caries susceptibility.[16]
• Enlarged pulp chambers and dentin hypomineralization are characteristic of hypophosphatemic forms, particularly XLH, predisposing to spontaneous periapical abscesses in caries-free teeth.[13][17]
• Delayed tooth eruption may accompany rickets in children.[18][19]
• Periodontal disease with alveolar bone loss is reported in chronic hypophosphatemic states.[11][17]

Complications and Red Flags

Pathologic fractures of the long bones, pelvis, and ribs are the most serious skeletal complication.[2][20] In the jaws, weakened bone may complicate dental extractions and implant placement. Persistent hypophosphatemia after correction of an apparent primary cause should raise suspicion for tumor-induced osteomalacia.[9][21]

Location and Distribution

Osteomalacia produces generalized, bilateral changes throughout the maxilla and mandible, reflecting its systemic nature.[5][22] No site predilection within the jaws has been established. The inferior cortex of the mandible is the most accessible region for assessment on panoramic radiography.[15][23]

Periphery and Shape

The disease does not produce a discrete focal lesion with a defined periphery. Instead, changes are diffuse and affect the entire skeleton, including both jaws.[1][24]

Internal Architecture

• Generalized osteopenia with reduced radiodensity of trabecular bone is the most common finding, manifesting as increased radiolucency and a coarsened or sparse trabecular pattern.[5][22][24]
• Thinning and porosity of cortical bone are characteristic; the inferior mandibular cortex may appear thin, porous, or eroded. Mandibular cortical width below 3 mm on panoramic radiography has been associated with reduced bone mineral density, though this finding is shared with osteoporosis.[5][15][23][25]
• Ground-glass appearance is not a feature of uncomplicated osteomalacia but may be seen when secondary hyperparathyroidism or renal osteodystrophy coexists.[24][26]

Looser Zones (Pseudofractures)

The Looser zone is the pathognomonic radiographic finding of osteomalacia: a radiolucent line oriented perpendicular to the cortical surface, often with a narrow rim of surrounding sclerosis.[1][10] These pseudofractures do not extend across the full width of the bone unless a complete fracture has occurred.[10] In the general skeleton, common locations include the medial proximal femur, pubic ramus, scapula, ribs, and ulna.[7][10] Looser zones in the jaws are rare but have been demonstrated on CBCT in the mandible.[5] They represent sites of mechanical stress or nutrient vessel entry where unmineralized osteoid accumulates.[10]

Effects on Teeth and Adjacent Structures

• Loss of lamina dura around tooth roots is a recognized finding in metabolic bone diseases with secondary hyperparathyroidism, including osteomalacia complicated by elevated parathyroid hormone.[22][27]
• Widening of the periodontal ligament space may be observed when secondary hyperparathyroidism is present.[27]
• Root resorption is not a typical feature of osteomalacia.
• In XLH, enlarged pulp chambers and periapical radiolucencies around apparently intact teeth are characteristic dental radiographic findings.[13][17][28]

Cortical Involvement and Extent

Cortical thinning is diffuse and bilateral. The mandibular inferior cortex may show erosion or porosity detectable on panoramic radiography, analogous to findings used in osteoporosis screening.[15][23][25] CBCT can demonstrate cortical thinning and porosity in three dimensions and may reveal pseudofractures not visible on conventional radiographs.[5]

Variants

• Rickets (in children with open growth plates): widened growth plates and frayed, cupped metaphyses of the mandibular condyle may occasionally be observed.[1][6]
• Tumor-induced osteomalacia: when the causative phosphaturic mesenchymal tumor arises in the jaws or adjacent craniofacial structures, it appears as a well-defined soft-tissue or intraosseous mass, often small and difficult to localize.[8][14]

Nuclear Medicine

Radionuclide bone scintigraphy may demonstrate increased uptake at sites of pseudofractures (Looser zones) and can identify occult stress fractures throughout the skeleton.[1] In tumor-induced osteomalacia, 68Ga-DOTA-based PET/CT (particularly 68Ga-DOTATATE) is the most sensitive functional imaging modality for localizing the causative phosphaturic mesenchymal tumor, which expresses somatostatin receptors.[8][29][30]

Medical CT and MRI

Medical CT can confirm cortical thinning and pseudofractures and is useful for surgical planning when a causative tumor is identified.[31] MRI may demonstrate bone marrow edema at fracture sites and aids in characterizing soft-tissue phosphaturic mesenchymal tumors.[31][32] Dual-energy X-ray absorptiometry (DXA) demonstrates reduced bone mineral density but cannot distinguish osteomalacia from osteoporosis.[32][33]

The radiographic differential of osteomalacia in the jaws centers on other conditions producing generalized osteopenia, loss of lamina dura, or diffuse jaw changes. Clinical history, serum biochemistry (calcium, phosphate, alkaline phosphatase, PTH, 25-hydroxyvitamin D), and correlation with systemic skeletal findings are essential for differentiation.

The highest-risk diagnostic pitfall is misdiagnosis of osteomalacia as osteoporosis, which may lead to inappropriate prescription of antiresorptive agents (bisphosphonates or denosumab) that can worsen the mineralization defect.[20] Serum biochemistry — particularly alkaline phosphatase, phosphate, 25-hydroxyvitamin D, and PTH — should be obtained before initiating antiresorptive therapy in any patient with unexplained osteopenia or fragility fractures.

Bone Biopsy Findings

Transiliac bone biopsy with prior tetracycline double-labeling remains the gold standard for definitive diagnosis of osteomalacia.[4][33][43]

• Increased osteoid volume, surface, and seam width on static histomorphometry are the hallmark findings, reflecting accumulation of unmineralized bone matrix.[4][33]
• Prolonged mineralization lag time on dynamic (fluorescence) histomorphometry, demonstrated by blurred or absent tetracycline labels, confirms the mineralization defect.[4][43]
• Irregular mineralization fronts and increased number of osteoid lamellae are characteristic.[44]

Calcipaenic Versus Phosphopaenic Patterns

• In calcipaenic osteomalacia (vitamin D or calcium deficiency), secondary hyperparathyroidism produces additional features: increased osteoclast surface, peritrabecular marrow fibrosis, and cortical thinning.[4]
• In phosphopaenic osteomalacia (e.g., XLH, TIO), osteoid accumulation predominates without prominent hyperparathyroid features; periosteocytic lesions (unmineralized halos around osteocytes) are characteristic of XLH.[12]

Radiologic-Pathologic Correlation

The generalized osteopenia seen radiographically corresponds to the combination of reduced mineralized bone volume and increased unmineralized osteoid. Looser zones represent focal accumulations of osteoid at sites of mechanical stress where mineralization has failed.[1][10] In aluminum-related osteomalacia (now rare), patchy calcification within thickened osteoid seams and aluminum lines at the mineralization front are distinctive histologic features.[45]

Dental Hard Tissue Findings

In hypophosphatemic forms, dentin shows hypomineralization with enlarged interglobular spaces, widened predentin, and increased porosity that permits bacterial penetration to the pulp, explaining the spontaneous periapical abscesses.[12][17][46]

Workup and Referral

When osteomalacia is suspected on dental radiographs — based on generalized osteopenia, cortical thinning, or loss of lamina dura — referral to an endocrinologist or metabolic bone specialist is indicated. Essential laboratory evaluation includes:[6][7][30]

• Serum 25-hydroxyvitamin D, calcium, phosphate, albumin
• Alkaline phosphatase (total and bone-specific)
• Parathyroid hormone
• Renal function (creatinine, eGFR)
• Urinary phosphate and calculation of TmP/GFR when hypophosphatemia is present

If hypophosphatemia with renal phosphate wasting is confirmed and no nutritional cause is identified, serum FGF23 measurement and functional imaging (68Ga-DOTATATE PET/CT) should be pursued to exclude tumor-induced osteomalacia.[8][30]

Treatment

• Nutritional osteomalacia: High-dose cholecalciferol or ergocalciferol for a minimum of 12 weeks, followed by lifelong maintenance supplementation; adequate calcium intake (diet or supplements) must be ensured.[3][6]
• Tumor-induced osteomalacia: Complete surgical resection of the causative phosphaturic mesenchymal tumor is curative. When the tumor is unresectable or unlocalized, medical management with phosphate salts plus active vitamin D, or burosumab (anti-FGF23 antibody), is recommended.[8][30]
• X-linked hypophosphatemia: Conventional therapy with oral phosphate and calcitriol improves skeletal and dental manifestations; burosumab provides more stable phosphate control and more reliable healing of rickets.[12]
• Renal osteomalacia: Correction of vitamin D deficiency, management of secondary hyperparathyroidism, and treatment of the underlying renal disease.[10]

Dental Management Considerations

Dental practitioners should be aware that osteomalacic bone is mechanically weakened, increasing the risk of pathologic fracture during extractions. Elective surgical procedures should be deferred until metabolic correction is achieved when feasible. In XLH, preventive dental care with sealants and regular monitoring for spontaneous periapical pathology is essential.[17][46]

Prognosis

Nutritional osteomalacia responds well to supplementation, with biochemical normalization typically within weeks and radiographic improvement over months.[2][6] Bone mineral density accrual after surgical cure of TIO is substantial in the short term but may take longer at peripheral sites.[32] Untreated osteomalacia leads to progressive skeletal pain, fractures, and disability.[2][20] Misdiagnosis as osteoporosis with subsequent antiresorptive therapy can worsen outcomes.[20]

X-Linked Hypophosphatemia and the Dentition

XLH deserves particular attention in oral and maxillofacial practice because dental manifestations — spontaneous periapical abscesses on caries-free teeth, enlarged pulp chambers, and dentin hypomineralization — may be the presenting or most troublesome feature.[13][17] Orthopantomographic assessment of pulp chamber size can aid in quantifying dentin dysplasia severity.[28] Burosumab has shown promise in improving skeletal outcomes, though long-term dental effects remain under investigation.[12]

Pregnancy and Lactation

Vitamin D deficiency during pregnancy can cause enamel hypoplasia of primary teeth in the offspring, and maternal osteomalacia may wor